Log in

185750 Chong Kun Dang Pharmaceutical Corp. KRX · South Korea

Chong Kun Dang Pharmaceutical (185750) news

Chong Kun Dang Pharmaceutical Corp. is a public biotech or pharmaceutical company listed on KRX under the ticker 185750, recorded under South Korea. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Chong Kun Dang Pharmaceutical news

We have not published a story on Chong Kun Dang Pharmaceutical yet. When there is news, it will appear here.

Questions about Chong Kun Dang Pharmaceutical

What is the ticker symbol of Chong Kun Dang Pharmaceutical?

Chong Kun Dang Pharmaceutical Corp. trades under the ticker 185750 on KRX.

Where is Chong Kun Dang Pharmaceutical listed?

Chong Kun Dang Pharmaceutical Corp. is listed on KRX.

Which country or territory is Chong Kun Dang Pharmaceutical listed under?

Our directory records Chong Kun Dang Pharmaceutical Corp. under South Korea.

What does Chong Kun Dang Pharmaceutical do?

Our directory classifies Chong Kun Dang Pharmaceutical Corp. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Chong Kun Dang Pharmaceutical?

The ISIN recorded for Chong Kun Dang Pharmaceutical Corp. is KR7185750007.

Does aibio.space cover Chong Kun Dang Pharmaceutical?

aibio.space lists Chong Kun Dang Pharmaceutical Corp. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Chong Kun Dang Pharmaceutical?

Companies in our directory listed in the same country and business area as Chong Kun Dang Pharmaceutical: MYUNGMOON Pharm Co., SAMSUNG PHARMACEUTICAL.CO.,Ltd., AHN-GOOK PHARMACEUTICAL Co., RPbio, Kyungnam Pharm Co., OPTUS Pharmaceutical Co..

Investor discussion: Chong Kun Dang Pharmaceutical

Members talk about Chong Kun Dang Pharmaceutical (185750). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open KRX:185750 on TradingView.

Listing details

Chong Kun Dang Pharmaceutical Corp. is a public biotech or pharmaceutical company listed on KRX under the ticker 185750, recorded under South Korea. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Chong Kun Dang Pharmaceutical Corp.
Ticker
185750
Listing
KRX
Country or territory
South Korea
Business scope
Pharmaceuticals: Major
ISIN
KR7185750007
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.